Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3766 Target Snapshot

Vasopressin V2 receptor · SINGLE PROTEIN · Rattus norvegicus

634Compounds
75Assays
7Approved Drugs
621.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q00788. Use UniProt Q00788 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q00788 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Vasopressin V2 receptor as ChEMBL target CHEMBL3766, mapped to UniProt Q00788. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Vasopressin V2 receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3766
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q00788
Vasopressin V2 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Vasopressin V2 receptor is the right protein anchor across sources, using UniProt Q00788 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelVasopressin V2 receptor
UniProt AccessionQ00788
Component TypeProtein
Sequence Length371 aa

Vasopressin V2 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Vasopressin V2 receptor, mapped to UniProt Q00788. Sequence length is 371 aa.

Mapped IDQ00788
Review nameVasopressin V2 receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

7
Approved
1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC50463.0
KI104.0
EC509.0
KD45.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4468523 10.7 EC50 0.02 Preclinical
CHEMBL1429 10.52 EC50 0.03 Approved
CHEMBL4539370 10.3 EC50 0.05 Preclinical
CHEMBL375324 9.7 Ki 0.2 Preclinical
CHEMBL435323 9.59 Ki 0.26 Preclinical
CHEMBL1429 9.52 Ki 0.3 Approved
CHEMBL221436 9.52 Ki 0.3 Preclinical
CHEMBL506235 9.4 Ki 0.4 Preclinical
CHEMBL373742 9.35 Ki 0.45 Approved
CHEMBL49429 9.3 IC50 0.5 Clinical
Distribution

pChEMBL Value Distribution

81
5.0
78
5.5
62
6.0
48
6.5
43
7.0
51
7.5
33
8.0
25
8.5
8
9.0
4
9.5
pChEMBL
Approved Drugs

Approved Drugs

VASOPRESSIN
CHEMBL373742
Approved 2014
MOZAVAPTAN
CHEMBL420762
Approved 2006
CONIVAPTAN
CHEMBL1755
Approved 2005
OXYTOCIN
CHEMBL395429
Approved 1980
DESMOPRESSIN
CHEMBL1429
Approved 1978
Assay Landscape

Assay Landscape

75
Total Assays
433
Tested Compounds
2
Assay Types
Binding — 60 assays, 433 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 30 133 7.0
tissue-based format 15 63 6.5
assay format 9 201 5.8
cell membrane format 4 34 7.5
cell-based format 2 2 8.6
Functional — 15 assays, 23 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 5 0
cell-based format 4 10 8.3
organism-based format 4 13 7.3
cell membrane format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine